On October 27, 2026, Merlin, Inc. announced a significant leadership change within its executive team. The company's Board of Directors appointed Mark Brunner as President, effective immediately. This move comes as Matthew George continues to serve as the Chief Executive Officer and Chairman of the Board.
Mark Brunner, age 60, has been with Merlin as Chief Revenue Officer since April 2026. His extensive background in defense technology includes roles such as Executive Vice President for PsiQuantum and President for Primer AI. Brunner has also served as a Vice President at The Cohen Group and has a notable history with the U.S. Navy.
This leadership transition is expected to influence the strategic direction of Merlin, particularly in the competitive landscape of computer integrated systems design. The company aims to leverage Brunner's experience to enhance its revenue strategies and operational effectiveness.
Background
Merlin, Inc. operates in the services sector, specifically focusing on computer integrated systems design, as indicated by its Standard Industrial Classification (SIC) code of 7373. The company is listed on the Nasdaq under the ticker symbol MRLN and is categorized as an emerging growth company.
What the Filing Says
The SEC filing states, "On October 27, 2026, the Board of Directors of Merlin, Inc. appointed Mr. Mark Brunner as President, effective immediately." It further notes that Matthew George will remain the Chief Executive Officer and Chairman of the Board.
Impact
This change may affect various stakeholders, including employees, investors, and clients, as leadership transitions often signal shifts in company strategy and priorities. Brunner's appointment could bring a fresh perspective to the company's operations and growth initiatives.
What's Next
The filing does not specify what happens next following this leadership change.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










